Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen for Post-Implantation Syndrome in EVAR
NCT03727412Unknown
- Sponsor
- University of Thessaly
- Start
- Aug 2018
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of naproxen in Post-implantation syndrome (PIS) and cardiovascular diseases (CVD) (2 arms), sponsored by University of Thessaly. Primary endpoint: Major Cardiovascular Events at 2 years. Status: unknown.
02
Drugs
naproxen
03
Conditions
Post-implantation syndrome (PIS)cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT03727412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03727412.